We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
124 hedge funds and large institutions have $558M invested in Arcturus Therapeutics in 2023 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 44 increasing their positions, 36 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
92% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 13
47% more capital invested
Capital invested by funds: $379M → $558M (+$179M)
22% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 36
10% more funds holding
Funds holding: 113 → 124 (+11)
2.35% more ownership
Funds ownership: 85.46% → 87.8% (+2.3%)
6% less call options, than puts
Call options by funds: $5.38M | Put options by funds: $5.69M
Holders
124
Holders Change
+11
Holders Change %
+9.73%
% of All Funds
1.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
44
Reduced
36
Closed
13
Calls
$5.38M
Puts
$5.69M
Net Calls
-$315K
Net Calls Change
-$4M
Top Buyers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$9.67M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$5.61M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
+$4.58M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.3M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.43M |
Top Sellers
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$16.1M |
| 2 |
BlackRock
New York
|
-$1.59M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.47M |
| 4 |
PVI
Pura Vida Investments
New York
|
-$848K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$788K |
